ExodusPoint Capital Management LP Has $3.59 Million Stock Holdings in Premier, Inc. (NASDAQ:PINC)

ExodusPoint Capital Management LP boosted its stake in shares of Premier, Inc. (NASDAQ:PINC - Free Report) by 408.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 169,458 shares of the company's stock after acquiring an additional 136,129 shares during the quarter. ExodusPoint Capital Management LP owned 0.18% of Premier worth $3,593,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Brooklyn Investment Group increased its position in shares of Premier by 61,750.0% during the 4th quarter. Brooklyn Investment Group now owns 1,237 shares of the company's stock worth $26,000 after purchasing an additional 1,235 shares in the last quarter. SRS Capital Advisors Inc. increased its holdings in shares of Premier by 157.8% during the fourth quarter. SRS Capital Advisors Inc. now owns 1,284 shares of the company's stock worth $27,000 after buying an additional 786 shares in the last quarter. Keystone Financial Group Inc. bought a new position in shares of Premier in the fourth quarter valued at approximately $37,000. Wilmington Savings Fund Society FSB bought a new position in shares of Premier in the third quarter valued at approximately $39,000. Finally, Smartleaf Asset Management LLC boosted its holdings in shares of Premier by 297.9% in the 4th quarter. Smartleaf Asset Management LLC now owns 1,906 shares of the company's stock worth $40,000 after acquiring an additional 1,427 shares in the last quarter. 74.41% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on PINC shares. Piper Sandler dropped their price target on Premier from $21.00 to $19.00 and set a "neutral" rating for the company in a report on Wednesday, February 5th. Canaccord Genuity Group lowered their target price on Premier from $21.00 to $19.00 and set a "hold" rating for the company in a research note on Wednesday, February 5th. Finally, Robert W. Baird cut their price target on Premier from $20.00 to $19.00 and set a "neutral" rating for the company in a report on Wednesday, February 5th. Eight analysts have rated the stock with a hold rating, According to MarketBeat.com, the company has an average rating of "Hold" and a consensus price target of $20.17.

Premier Price Performance

Shares of PINC stock traded down $0.04 on Friday, reaching $19.21. 1,638,266 shares of the stock were exchanged, compared to its average volume of 1,265,681. Premier, Inc. has a one year low of $17.23 and a one year high of $23.56. The stock has a market cap of $1.75 billion, a PE ratio of -192.08 and a beta of 0.51. The stock has a 50 day moving average price of $18.63 and a 200 day moving average price of $20.41.

Premier Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Saturday, March 15th. Shareholders of record on Saturday, March 1st were issued a dividend of $0.21 per share. The ex-dividend date was Friday, February 28th. This represents a $0.84 annualized dividend and a yield of 4.37%. Premier's dividend payout ratio is currently -840.00%.

Insider Buying and Selling at Premier

In other Premier news, General Counsel David L. Klatsky sold 10,000 shares of the company's stock in a transaction on Wednesday, April 2nd. The shares were sold at an average price of $19.53, for a total transaction of $195,300.00. Following the completion of the sale, the general counsel now owns 90,597 shares in the company, valued at approximately $1,769,359.41. The trade was a 9.94 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 0.96% of the company's stock.

About Premier

Premier, Inc, together with its subsidiaries, operates as a healthcare improvement company in the United States. It operates in two segments, Supply Chain Services and Performance Services. The Supply Chain Services segment offers its members with an access to a range of products and services, including medical and surgical products, pharmaceuticals, laboratory supplies, capital equipment, information technology, facilities and construction, and food and nutritional products, as well as purchased services, such as clinical engineering and workforce solutions.